[HTML][HTML] Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
HJ Park, HJ Jang, TH Kim, SW Kwon… - Reviews in …, 2022 - imrpress.com
Background: For the Asian patients with STEMI undergoing PCI, ACEIs are known to have a
better outcome than ARBs. However, there is limited evidence to suggest so. Methods …
better outcome than ARBs. However, there is limited evidence to suggest so. Methods …
Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
HJ Park, HJ Jang, TH Kim, SW Kwon… - Reviews in …, 2022 - pubmed.ncbi.nlm.nih.gov
Background For the Asian patients with STEMI undergoing PCI, ACEIs are known to have a
better outcome than ARBs. However, there is limited evidence to suggest so. Methods …
better outcome than ARBs. However, there is limited evidence to suggest so. Methods …
[PDF][PDF] Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
HJ Park, HJ Jang, TH Kim, SW Kwon… - Rev. Cardiovasc …, 2022 - article.imrpress.com
Abstract Background: For the Asian patients with STEMI undergoing PCI, ACEIs are known
to have a better outcome than ARBs. However, there is limited evidence to suggest so …
to have a better outcome than ARBs. However, there is limited evidence to suggest so …
[PDF][PDF] Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
HJ Park, HJ Jang, TH Kim, SW Kwon… - Rev. Cardiovasc …, 2022 - scholar.archive.org
Abstract Background: For the Asian patients with STEMI undergoing PCI, ACEIs are known
to have a better outcome than ARBs. However, there is limited evidence to suggest so …
to have a better outcome than ARBs. However, there is limited evidence to suggest so …
Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
HJ Park, HJ Jang, TH Kim, SW Kwon, SD Park… - 2022 - scholarworks.bwise.kr
Background: For the Asian patients with STEMI undergoing PCI, ACEIs are known to have a
better outcome than ARBs. However, there is limited evidence to suggest so. Methods …
better outcome than ARBs. However, there is limited evidence to suggest so. Methods …
Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization.
HJ Park, HJ Jang, TH Kim, SW Kwon… - Reviews in …, 2022 - europepmc.org
Background For the Asian patients with STEMI undergoing PCI, ACEIs are known to have a
better outcome than ARBs. However, there is limited evidence to suggest so. Methods …
better outcome than ARBs. However, there is limited evidence to suggest so. Methods …
Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
HJ Park, HJ Jang, TH Kim, SW Kwon… - Reviews in …, 2022 - imrpress.com
Background: For the Asian patients with STEMI undergoing PCI, ACEIs are known to have a
better outcome than ARBs. However, there is limited evidence to suggest so. Methods …
better outcome than ARBs. However, there is limited evidence to suggest so. Methods …
Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
HJ Park, HJ Jang, TH Kim, SW Kwon, SD Park… - 2022 - scholarworks.bwise.kr
Background: For the Asian patients with STEMI undergoing PCI, ACEIs are known to have a
better outcome than ARBs. However, there is limited evidence to suggest so. Methods …
better outcome than ARBs. However, there is limited evidence to suggest so. Methods …